Royalty Pharma
RPRX
#1044
Rank
HK$140.64 B
Marketcap
HK$243.99
Share price
-0.88%
Change (1 day)
2.66%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2023 (TTM): HK$4.35

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is HK$4.28. In 2022 the company made an earnings per share (EPS) of HK$0.78 a decrease over its 2021 EPS that were of HK$11.67.

EPS history for Royalty Pharma from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$4.35459.23%
2022HK$0.78-93.33%
2021HK$11.67-1.33%
2020HK$11.82-77.07%
2019HK$51.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$3.66-185.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.12 440.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.23 887.14%๐Ÿ‡บ๐Ÿ‡ธ USA